Structure

Physi-Chem Properties

Molecular Weight:  418.09
Volume:  387.061
LogP:  1.321
LogD:  0.909
LogS:  -4.299
# Rotatable Bonds:  4
TPSA:  170.05
# H-Bond Aceptor:  10
# H-Bond Donor:  6
# Rings:  4
# Heavy Atoms:  10

MedChem Properties

QED Drug-Likeness Score:  0.348
Synthetic Accessibility Score:  3.708
Fsp3:  0.25
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.835
MDCK Permeability:  9.744348972162697e-06
Pgp-inhibitor:  0.025
Pgp-substrate:  0.623
Human Intestinal Absorption (HIA):  0.264
20% Bioavailability (F20%):  0.014
30% Bioavailability (F30%):  0.994

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.016
Plasma Protein Binding (PPB):  91.32378387451172%
Volume Distribution (VD):  0.988
Pgp-substrate:  10.70513916015625%

ADMET: Metabolism

CYP1A2-inhibitor:  0.386
CYP1A2-substrate:  0.049
CYP2C19-inhibitor:  0.031
CYP2C19-substrate:  0.052
CYP2C9-inhibitor:  0.115
CYP2C9-substrate:  0.792
CYP2D6-inhibitor:  0.495
CYP2D6-substrate:  0.193
CYP3A4-inhibitor:  0.309
CYP3A4-substrate:  0.021

ADMET: Excretion

Clearance (CL):  4.893
Half-life (T1/2):  0.841

ADMET: Toxicity

hERG Blockers:  0.057
Human Hepatotoxicity (H-HT):  0.139
Drug-inuced Liver Injury (DILI):  0.98
AMES Toxicity:  0.802
Rat Oral Acute Toxicity:  0.183
Maximum Recommended Daily Dose:  0.014
Skin Sensitization:  0.874
Carcinogencity:  0.073
Eye Corrosion:  0.003
Eye Irritation:  0.419
Respiratory Toxicity:  0.034

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC288084

Natural Product ID:  NPC288084
Common Name*:   Juglanin
IUPAC Name:   3-[(2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one
Synonyms:   Juglanin
Standard InCHIKey:  POQICXMTUPVZMX-UXYNSRGZSA-N
Standard InCHI:  InChI=1S/C20H18O10/c21-7-13-15(25)17(27)20(29-13)30-19-16(26)14-11(24)5-10(23)6-12(14)28-18(19)8-1-3-9(22)4-2-8/h1-6,13,15,17,20-25,27H,7H2/t13-,15-,17+,20-/m0/s1
SMILES:  c1cc(ccc1c1c(c(=O)c2c(cc(cc2o1)O)O)O[C@H]1[C@@H]([C@H]([C@H](CO)O1)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL469440
PubChem CID:   5318717
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0001111] Flavonoid glycosides
          • [CHEMONTID:0001583] Flavonoid O-glycosides
            • [CHEMONTID:0003531] Flavonoid-3-O-glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO3057 Polygonum aviculare Species Polygonaceae Eukaryota n.a. whole plant n.a. DOI[10.1016/S1572-557X(05)02007-6]
NPO22608 Excoecaria agallocha Species Euphorbiaceae Eukaryota n.a. n.a. n.a. PMID[21190854]
NPO22608 Excoecaria agallocha Species Euphorbiaceae Eukaryota stems and twigs Beihai, Guangxi province, China 2008-Jan PMID[22196120]
NPO22608 Excoecaria agallocha Species Euphorbiaceae Eukaryota n.a. leaf n.a. PMID[7623051]
NPO22608 Excoecaria agallocha Species Euphorbiaceae Eukaryota n.a. twig n.a. PMID[7623051]
NPO22608 Excoecaria agallocha Species Euphorbiaceae Eukaryota n.a. n.a. n.a. PMID[7623051]
NPO22608 Excoecaria agallocha Species Euphorbiaceae Eukaryota n.a. bark n.a. PMID[7623051]
NPO3057 Polygonum aviculare Species Polygonaceae Eukaryota n.a. n.a. n.a. Database[Article]
NPO1982 Tilia miqueliana Species Malvaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO22608 Excoecaria agallocha Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO21919 Polysaccharidum versicolor n.a. n.a. n.a. n.a. n.a. n.a. Database[HerDing]
NPO3057 Polygonum aviculare Species Polygonaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO3057 Polygonum aviculare Species Polygonaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO1982 Tilia miqueliana Species Malvaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO21919 Polysaccharidum versicolor n.a. n.a. n.a. n.a. n.a. n.a. Database[TCMID]
NPO22608 Excoecaria agallocha Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO3057 Polygonum aviculare Species Polygonaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO22608 Excoecaria agallocha Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO3057 Polygonum aviculare Species Polygonaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO15245 Paenibacillus macerans Species Paenibacillaceae Bacteria n.a. n.a. n.a. Database[UNPD]
NPO2675 Cordyline neocaledonica Species Asparagaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO8343 Centaurea corcubionensis Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO1189 Aspergillus giganteus Species Aspergillaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO10919 Salvia cyanescens Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO10444 Dendrophthoe falcata Species Loranthaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO1982 Tilia miqueliana Species Malvaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO12044 Dorstenia barteri Species Moraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO22608 Excoecaria agallocha Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1310 Individual Protein Xanthine dehydrogenase Bos taurus Inhibition = 0.0 % PMID[503216]
NPT461 Cell Line PANC-1 Homo sapiens IC50 = 1800.0 nM PMID[503217]
NPT90 Cell Line DU-145 Homo sapiens IC50 = 2400.0 nM PMID[503217]
NPT2 Others Unspecified IC50 = 2000.0 nM PMID[503217]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 100000.0 nM PMID[503217]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC288084 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9739 High Similarity NPC150164
0.9735 High Similarity NPC77672
0.9735 High Similarity NPC54802
0.9735 High Similarity NPC133671
0.9735 High Similarity NPC78263
0.9735 High Similarity NPC135391
0.9735 High Similarity NPC197304
0.9671 High Similarity NPC320283
0.9671 High Similarity NPC41121
0.9671 High Similarity NPC472459
0.9671 High Similarity NPC111929
0.9669 High Similarity NPC203500
0.9669 High Similarity NPC307938
0.9669 High Similarity NPC323593
0.9613 High Similarity NPC72016
0.9608 High Similarity NPC470405
0.9608 High Similarity NPC471079
0.9608 High Similarity NPC304741
0.9605 High Similarity NPC182634
0.9605 High Similarity NPC108831
0.9605 High Similarity NPC122809
0.9551 High Similarity NPC255615
0.9551 High Similarity NPC67037
0.9545 High Similarity NPC476215
0.9545 High Similarity NPC249281
0.9545 High Similarity NPC246943
0.9545 High Similarity NPC259957
0.9545 High Similarity NPC173582
0.9545 High Similarity NPC253788
0.9545 High Similarity NPC159579
0.9545 High Similarity NPC139320
0.9545 High Similarity NPC181465
0.9545 High Similarity NPC135846
0.9545 High Similarity NPC470125
0.9545 High Similarity NPC297987
0.9545 High Similarity NPC129217
0.9545 High Similarity NPC48093
0.9545 High Similarity NPC116458
0.9545 High Similarity NPC282169
0.9545 High Similarity NPC276377
0.9545 High Similarity NPC163242
0.9545 High Similarity NPC85707
0.9545 High Similarity NPC215710
0.9545 High Similarity NPC473438
0.9545 High Similarity NPC224530
0.9545 High Similarity NPC170052
0.9545 High Similarity NPC265885
0.9545 High Similarity NPC216496
0.9545 High Similarity NPC64305
0.9539 High Similarity NPC149368
0.9539 High Similarity NPC265480
0.9536 High Similarity NPC210003
0.9536 High Similarity NPC39360
0.9536 High Similarity NPC83283
0.9536 High Similarity NPC29763
0.9536 High Similarity NPC143851
0.9487 High Similarity NPC34531
0.9484 High Similarity NPC240306
0.9484 High Similarity NPC27942
0.9481 High Similarity NPC187379
0.9481 High Similarity NPC136761
0.9481 High Similarity NPC153342
0.9477 High Similarity NPC6985
0.9474 High Similarity NPC27408
0.9474 High Similarity NPC95090
0.947 High Similarity NPC259182
0.947 High Similarity NPC88484
0.947 High Similarity NPC121001
0.947 High Similarity NPC259767
0.9427 High Similarity NPC254306
0.9423 High Similarity NPC278419
0.9423 High Similarity NPC179198
0.9423 High Similarity NPC66087
0.9423 High Similarity NPC121703
0.9416 High Similarity NPC104677
0.9408 High Similarity NPC106625
0.9367 High Similarity NPC149244
0.9367 High Similarity NPC48640
0.9363 High Similarity NPC19240
0.9363 High Similarity NPC289667
0.9363 High Similarity NPC85751
0.9363 High Similarity NPC292929
0.9363 High Similarity NPC205824
0.9363 High Similarity NPC76831
0.9363 High Similarity NPC129264
0.9359 High Similarity NPC131745
0.9355 High Similarity NPC306978
0.9355 High Similarity NPC200708
0.9351 High Similarity NPC161749
0.9351 High Similarity NPC65003
0.9351 High Similarity NPC473512
0.9351 High Similarity NPC60966
0.9351 High Similarity NPC197896
0.9351 High Similarity NPC44931
0.9351 High Similarity NPC313163
0.9351 High Similarity NPC156457
0.9351 High Similarity NPC258035
0.9351 High Similarity NPC129827
0.9346 High Similarity NPC39351
0.9346 High Similarity NPC72649
0.9346 High Similarity NPC97052
0.9346 High Similarity NPC99233
0.9346 High Similarity NPC26195
0.9346 High Similarity NPC169248
0.9338 High Similarity NPC191154
0.9313 High Similarity NPC245452
0.9308 High Similarity NPC476771
0.9304 High Similarity NPC118284
0.9304 High Similarity NPC256188
0.9304 High Similarity NPC11432
0.9304 High Similarity NPC64425
0.9304 High Similarity NPC274618
0.9304 High Similarity NPC56077
0.9304 High Similarity NPC12013
0.9304 High Similarity NPC179950
0.9304 High Similarity NPC281131
0.9304 High Similarity NPC476470
0.9304 High Similarity NPC32641
0.9304 High Similarity NPC189564
0.9304 High Similarity NPC221342
0.9304 High Similarity NPC142142
0.9304 High Similarity NPC88789
0.9304 High Similarity NPC477613
0.9304 High Similarity NPC145038
0.9304 High Similarity NPC203145
0.9304 High Similarity NPC186816
0.9304 High Similarity NPC276222
0.9304 High Similarity NPC253662
0.9304 High Similarity NPC308404
0.9299 High Similarity NPC80068
0.9299 High Similarity NPC183672
0.929 High Similarity NPC473634
0.929 High Similarity NPC73511
0.929 High Similarity NPC22062
0.929 High Similarity NPC138811
0.9286 High Similarity NPC261866
0.9286 High Similarity NPC206378
0.9286 High Similarity NPC127406
0.9286 High Similarity NPC170475
0.9276 High Similarity NPC134819
0.925 High Similarity NPC72249
0.9245 High Similarity NPC84362
0.9245 High Similarity NPC223424
0.9245 High Similarity NPC317489
0.9245 High Similarity NPC173637
0.9245 High Similarity NPC127546
0.9245 High Similarity NPC52550
0.9241 High Similarity NPC139060
0.9241 High Similarity NPC19388
0.9241 High Similarity NPC55786
0.9241 High Similarity NPC240431
0.9241 High Similarity NPC277205
0.9241 High Similarity NPC287889
0.9241 High Similarity NPC135358
0.9236 High Similarity NPC259834
0.9231 High Similarity NPC473623
0.9226 High Similarity NPC43638
0.9226 High Similarity NPC470606
0.9226 High Similarity NPC23817
0.9205 High Similarity NPC199335
0.9205 High Similarity NPC287294
0.9193 High Similarity NPC476772
0.9187 High Similarity NPC120099
0.9187 High Similarity NPC223747
0.9187 High Similarity NPC5319
0.9187 High Similarity NPC219904
0.9187 High Similarity NPC225434
0.9187 High Similarity NPC203050
0.9182 High Similarity NPC113968
0.9182 High Similarity NPC135599
0.9182 High Similarity NPC277174
0.9182 High Similarity NPC73855
0.9182 High Similarity NPC328940
0.9182 High Similarity NPC21100
0.9182 High Similarity NPC197285
0.9172 High Similarity NPC477629
0.9172 High Similarity NPC210961
0.9172 High Similarity NPC195685
0.9172 High Similarity NPC47923
0.9172 High Similarity NPC270675
0.9172 High Similarity NPC477628
0.9172 High Similarity NPC472994
0.9172 High Similarity NPC303913
0.9172 High Similarity NPC101636
0.9167 High Similarity NPC308265
0.9167 High Similarity NPC470607
0.9161 High Similarity NPC473657
0.9161 High Similarity NPC45165
0.9161 High Similarity NPC295613
0.9156 High Similarity NPC268950
0.9156 High Similarity NPC108706
0.9156 High Similarity NPC211158
0.9156 High Similarity NPC78021
0.9156 High Similarity NPC87304
0.915 High Similarity NPC23253
0.9141 High Similarity NPC296018
0.9141 High Similarity NPC154741
0.9139 High Similarity NPC23084
0.913 High Similarity NPC96605
0.913 High Similarity NPC95866

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC288084 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9351 High Similarity NPD4381 Clinical (unspecified phase)
0.9187 High Similarity NPD7804 Clinical (unspecified phase)
0.9125 High Similarity NPD3818 Discontinued
0.9074 High Similarity NPD6797 Phase 2
0.9018 High Similarity NPD7251 Discontinued
0.8963 High Similarity NPD7808 Phase 3
0.8963 High Similarity NPD4338 Clinical (unspecified phase)
0.8846 High Similarity NPD6801 Discontinued
0.8834 High Similarity NPD7054 Approved
0.878 High Similarity NPD7472 Approved
0.8766 High Similarity NPD5403 Approved
0.8742 High Similarity NPD7075 Discontinued
0.8718 High Similarity NPD4380 Phase 2
0.8693 High Similarity NPD6799 Approved
0.8667 High Similarity NPD7074 Phase 3
0.8636 High Similarity NPD4378 Clinical (unspecified phase)
0.8636 High Similarity NPD5401 Approved
0.8616 High Similarity NPD3817 Phase 2
0.8563 High Similarity NPD6559 Discontinued
0.8562 High Similarity NPD3882 Suspended
0.8553 High Similarity NPD7096 Clinical (unspecified phase)
0.8543 High Similarity NPD1552 Clinical (unspecified phase)
0.8543 High Similarity NPD1550 Clinical (unspecified phase)
0.85 High Similarity NPD5402 Approved
0.8487 Intermediate Similarity NPD1549 Phase 2
0.8462 Intermediate Similarity NPD1512 Approved
0.8424 Intermediate Similarity NPD6166 Phase 2
0.8424 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8424 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8375 Intermediate Similarity NPD1934 Approved
0.8365 Intermediate Similarity NPD6599 Discontinued
0.8333 Intermediate Similarity NPD1511 Approved
0.8323 Intermediate Similarity NPD2801 Approved
0.8323 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8289 Intermediate Similarity NPD1510 Phase 2
0.8235 Intermediate Similarity NPD2796 Approved
0.8165 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8086 Intermediate Similarity NPD7411 Suspended
0.8049 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8026 Intermediate Similarity NPD1240 Approved
0.8 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7922 Intermediate Similarity NPD1607 Approved
0.7921 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7911 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7895 Intermediate Similarity NPD3751 Discontinued
0.7879 Intermediate Similarity NPD7819 Suspended
0.787 Intermediate Similarity NPD3787 Discontinued
0.7861 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7824 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7799 Intermediate Similarity NPD3750 Approved
0.7778 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD1551 Phase 2
0.7751 Intermediate Similarity NPD5494 Approved
0.7747 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7738 Intermediate Similarity NPD3749 Approved
0.773 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7706 Intermediate Similarity NPD7199 Phase 2
0.7706 Intermediate Similarity NPD6959 Discontinued
0.7692 Intermediate Similarity NPD919 Approved
0.7688 Intermediate Similarity NPD4628 Phase 3
0.7683 Intermediate Similarity NPD1653 Approved
0.7674 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7673 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.766 Intermediate Similarity NPD7584 Approved
0.7627 Intermediate Similarity NPD8312 Approved
0.7627 Intermediate Similarity NPD8313 Approved
0.7625 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7625 Intermediate Similarity NPD2800 Approved
0.7622 Intermediate Similarity NPD920 Approved
0.7607 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7602 Intermediate Similarity NPD1247 Approved
0.7595 Intermediate Similarity NPD7033 Discontinued
0.7593 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7574 Intermediate Similarity NPD7768 Phase 2
0.7571 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.756 Intermediate Similarity NPD8455 Phase 2
0.7558 Intermediate Similarity NPD6232 Discontinued
0.7548 Intermediate Similarity NPD6798 Discontinued
0.7533 Intermediate Similarity NPD1091 Approved
0.7529 Intermediate Similarity NPD7473 Discontinued
0.7527 Intermediate Similarity NPD6781 Approved
0.7527 Intermediate Similarity NPD6778 Approved
0.7527 Intermediate Similarity NPD6782 Approved
0.7527 Intermediate Similarity NPD6776 Approved
0.7527 Intermediate Similarity NPD6777 Approved
0.7527 Intermediate Similarity NPD6779 Approved
0.7527 Intermediate Similarity NPD6780 Approved
0.7516 Intermediate Similarity NPD1243 Approved
0.7514 Intermediate Similarity NPD3926 Phase 2
0.75 Intermediate Similarity NPD2532 Approved
0.75 Intermediate Similarity NPD2534 Approved
0.75 Intermediate Similarity NPD6233 Phase 2
0.75 Intermediate Similarity NPD37 Approved
0.75 Intermediate Similarity NPD7435 Discontinued
0.75 Intermediate Similarity NPD2533 Approved
0.7485 Intermediate Similarity NPD6234 Discontinued
0.7484 Intermediate Similarity NPD3748 Approved
0.7471 Intermediate Similarity NPD4965 Approved
0.7471 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7471 Intermediate Similarity NPD4967 Phase 2
0.7471 Intermediate Similarity NPD4966 Approved
0.7451 Intermediate Similarity NPD1203 Approved
0.7443 Intermediate Similarity NPD5844 Phase 1
0.7439 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7423 Intermediate Similarity NPD6190 Approved
0.7419 Intermediate Similarity NPD6832 Phase 2
0.7416 Intermediate Similarity NPD7685 Pre-registration
0.7405 Intermediate Similarity NPD1933 Approved
0.7405 Intermediate Similarity NPD6355 Discontinued
0.7403 Intermediate Similarity NPD8434 Phase 2
0.7391 Intermediate Similarity NPD2344 Approved
0.7386 Intermediate Similarity NPD7228 Approved
0.7383 Intermediate Similarity NPD1548 Phase 1
0.736 Intermediate Similarity NPD5953 Discontinued
0.7358 Intermediate Similarity NPD6651 Approved
0.7353 Intermediate Similarity NPD1465 Phase 2
0.7348 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7345 Intermediate Similarity NPD7286 Phase 2
0.7342 Intermediate Similarity NPD1613 Approved
0.7342 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7329 Intermediate Similarity NPD2935 Discontinued
0.7325 Intermediate Similarity NPD2313 Discontinued
0.7316 Intermediate Similarity NPD7698 Approved
0.7316 Intermediate Similarity NPD7696 Phase 3
0.7316 Intermediate Similarity NPD7697 Approved
0.7303 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7301 Intermediate Similarity NPD1652 Phase 2
0.729 Intermediate Similarity NPD2798 Approved
0.7277 Intermediate Similarity NPD7871 Phase 2
0.7277 Intermediate Similarity NPD7870 Phase 2
0.7268 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7268 Intermediate Similarity NPD7874 Approved
0.7258 Intermediate Similarity NPD6535 Approved
0.7258 Intermediate Similarity NPD6534 Approved
0.7254 Intermediate Similarity NPD7701 Phase 2
0.7254 Intermediate Similarity NPD7585 Approved
0.7233 Intermediate Similarity NPD943 Approved
0.7219 Intermediate Similarity NPD7458 Discontinued
0.7216 Intermediate Similarity NPD8151 Discontinued
0.7215 Intermediate Similarity NPD3268 Approved
0.7212 Intermediate Similarity NPD2309 Approved
0.7202 Intermediate Similarity NPD7583 Approved
0.7195 Intermediate Similarity NPD2654 Approved
0.719 Intermediate Similarity NPD422 Phase 1
0.7188 Intermediate Similarity NPD4340 Discontinued
0.7186 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7175 Intermediate Similarity NPD2403 Approved
0.717 Intermediate Similarity NPD4062 Phase 3
0.7166 Intermediate Similarity NPD4360 Phase 2
0.7166 Intermediate Similarity NPD4363 Phase 3
0.7161 Intermediate Similarity NPD3225 Approved
0.716 Intermediate Similarity NPD2799 Discontinued
0.7143 Intermediate Similarity NPD7783 Phase 2
0.7143 Intermediate Similarity NPD7700 Phase 2
0.7143 Intermediate Similarity NPD9717 Approved
0.7143 Intermediate Similarity NPD7801 Approved
0.7143 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7699 Phase 2
0.7135 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7128 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7128 Intermediate Similarity NPD4361 Phase 2
0.7118 Intermediate Similarity NPD3226 Approved
0.7115 Intermediate Similarity NPD2797 Approved
0.7108 Intermediate Similarity NPD3887 Approved
0.7108 Intermediate Similarity NPD2354 Approved
0.7098 Intermediate Similarity NPD8319 Approved
0.7098 Intermediate Similarity NPD8320 Phase 1
0.7089 Intermediate Similarity NPD4908 Phase 1
0.7089 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7083 Intermediate Similarity NPD6823 Phase 2
0.7081 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7081 Intermediate Similarity NPD230 Phase 1
0.7081 Intermediate Similarity NPD5124 Phase 1
0.7078 Intermediate Similarity NPD1610 Phase 2
0.7073 Intermediate Similarity NPD7266 Discontinued
0.7055 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7044 Intermediate Similarity NPD3027 Phase 3
0.7035 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7033 Intermediate Similarity NPD7240 Approved
0.7025 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7012 Intermediate Similarity NPD6100 Approved
0.7012 Intermediate Similarity NPD6099 Approved
0.7 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.6983 Remote Similarity NPD4575 Clinical (unspecified phase)
0.6982 Remote Similarity NPD4662 Approved
0.6982 Remote Similarity NPD4661 Approved
0.6975 Remote Similarity NPD447 Suspended
0.6975 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6966 Remote Similarity NPD5710 Approved
0.6966 Remote Similarity NPD5711 Approved
0.6951 Remote Similarity NPD4308 Phase 3
0.695 Remote Similarity NPD7930 Approved
0.6941 Remote Similarity NPD5049 Phase 3
0.6935 Remote Similarity NPD8150 Discontinued
0.6928 Remote Similarity NPD2424 Discontinued
0.6928 Remote Similarity NPD9545 Approved
0.6923 Remote Similarity NPD1729 Discontinued
0.6923 Remote Similarity NPD7390 Discontinued
0.6914 Remote Similarity NPD4288 Approved
0.6914 Remote Similarity NPD4060 Phase 1

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data